ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$262.10
Tradestie Score
57
Market Cap
$431.71B
P/E Ratio
74.5
Revenue Growth
0.1%
Analyst Upside
+6.4%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1143.60
|
$739.95B | 39.8 | 48 | Compare |
|
JNJ
Johnson & Johnson
|
$255.48
|
$448.07B | 31.1 | 52 | Compare |
|
NVO
Novo-Nordisk A/S
|
$37.18
|
$262.92B | 9.5 | 45 | Compare |
|
AZN
AstraZeneca PLC
|
$156.53
|
$261.56B | 24.0 | 47 | Compare |
|
NVS
Novartis AG
|
$140.14
|
$254.99B | 22.0 | 66 | Compare |
|
ABT
Abbott Laboratories
|
$97.33
|
$232.30B | 32.7 | 38 | Compare |
|
MRK
Merck & Co., Inc.
|
$143.47
|
$225.13B | 116.2 | 55 | Compare |
|
AMGN
Amgen Inc
|
$404.06
|
$160.70B | 26.3 | 55 | Compare |
|
PFE
Pfizer Inc.
|
$27.52
|
$154.70B | 37.5 | 53 | Compare |
|
GILD
Gilead Sciences Inc
|
$144.43
|
$137.92B | - | 46 | Compare |
More ABBV Analysis
Data updated: Oct 02, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry